Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-05-09

Clinical Trial Update: Tolerability Comparison of Differin® Cream 0.1% Versus Differin® Lotion 0.1% in Subjects With Healthy Skin [Phase 1]

View source ↗

Summary

Phase 1 trial comparing tolerability of Differin cream 0.1% versus Differin lotion 0.1% in healthy skin; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DIFFERIN (ADAPALENE)

Snippet

Sponsor: Galderma R&D | Conditions: Skin Manifestations | Phase 1 | Status: COMPLETED | Results posted: 2011-05-09